FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:1335-1337 May 16, 1996 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Baldini, N. PubMed Citation

To the Editor: Although the publication of questionable immunocytochemical illustrations — and results — is unfortunately not infrequent, Figure 1 of the article by Baldini et al. (Nov. 23 issue)¹ cannot be ignored, particularly because the conclusions and suggested therapeutic implications of this study were based exclusively on the immunocytochemical data. Neither I nor 21 colleagues (including pathologists, nonpathologists, and Ph.D.s) could distinguish or differentiate the results shown in Figure 1B from those in Figure 1C, nor could we discriminate with any level of confidence the specific localization of antigen within the diffuse, fairly homogeneous, light-brown stained areas in Figure . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Gorlick, R., Huvos, A. G., Heller, G., Aledo, A., Beardsley, G. P., Healey, J. H., Meyers, P. A. (1999). Expression of HER2/erbB-2 Correlates With Survival in Osteosarcoma. JCO 17: 2781-2781 [Abstract] [Full Text]